表紙
市場調查報告書

分子診斷的全球市場:各用途、各技術、各終端用戶、各地區、各企業的預測

Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies

出版商 Renub Research 商品編碼 204217
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
分子診斷的全球市場:各用途、各技術、各終端用戶、各地區、各企業的預測 Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies
出版日期: 2020年01月02日內容資訊: 英文 170 Pages
簡介

本報告提供全球分子診斷市場現狀與未來的預測調查分析,各用途、技術、地區及各主要企業的市場分析與預測提供,推動市場的要素與課題,臨床試驗狀況等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 全球分子診斷市場

第3章 市場佔有率:全球分子診斷市場

  • 各用途
  • 各技術
  • 各國
  • 各企業

第4章 各用途分析:分子診斷市場

  • 感染疾病
    • 院內感染疾病 (HAI)
    • HIV/HVC檢驗
    • STD檢驗
    • HPV檢驗
  • 血液篩檢
  • 腫瘤/癌症
    • 乳癌
    • 大腸癌症
    • 前列腺癌症
    • 其他
  • 遺傳基因檢驗
  • HLA (組織型判斷)
  • 細菌檢驗
  • 心血管疾病
  • 神經疾病
  • 藥理基因學
  • 其他

第5章 各技術分析:分子診斷市場

  • PCR (聚合酶連鎖反應)
  • TMA (轉錄擴增法)
  • 混合化
  • DNA定序和NGS (次世代定序)
  • 微陣列
  • 其他

第6章 各地區分析:分子診斷市場

  • 美國
  • 歐洲
  • 印度
  • 中國
  • 日本
  • 巴西
  • 韓國
  • 墨西哥
  • 俄羅斯
  • 其他的國家 (RoW)

第7章 終端用戶:分子診斷市場

  • 醫院、教育機關的檢驗室
  • 臨床/民間檢驗室
  • 其他

第8章 Roche Diagnostics:企業分析

  • 企業合併、收購 (M&A)
  • 銷售額分析

第9章 Abbott Laboratories:企業分析

第10章 Myriad Genetics:企業分析

第11章 Qiagen:企業分析

第12章 BioMerieux's Inc:企業分析

第13章 推動市場要素

第14章 課題

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis despite rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug resistant occurs in many people across the world. Nowadays, a new diagnostic procedure is being followed to fight infectious disease like molecular diagnostic test is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at rapid pace. Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025.

There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc. In addition, increasing prevalence of genetic disorder will further boost the market in forecast period of time.

Renub Research report titled "Molecular Diagnostics Market Share & Forecast, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMerieux and Others)" provides a complete analysis of Molecular Diagnostics Market.

Market Insight by Application

The report provides comprehensive analysis of molecular diagnostic test market by application into ten parts: Infectious Diseases, Genetic Testing, Blood Screening, Oncology, HLA (Tissue Typing), Microbiology, Neurological Diseases, Pharmacogenomics, Cardiovascular Diseases, and Others. This report also provides key opportunities market and specific factors are given by each application market.

Market Insight by Technology

Here the market is fragmented into six parts; PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others. Besides, many factors are analyzed that influence the growth, challenges and opportunities of market in technological context.

Market Insight by End User

The report provides complete insight of market by End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to Renub Research Analysis, Hospitals & Academic Laboratories will hold the largest market in global molecular diagnostic test market in forecast period of time.

Market Insight by Regions

This report covers the complete regional profile by 10 geographical market; United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World (ROW).

By Application

  • Infectious Diseases
  • Blood Screening
  • Oncology
  • Genetic Testing
  • HLA (Tissue Typing)
  • Microbiology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Pharmacogenomics
  • Others

By Technology

  • PCR
  • Transcription-Mediated Amplification (TMA)
  • Hybridiazation (In-situ Hybridiazation & FISH)
  • DNA Sequencing & NGS
  • Microarray
  • Others

By End User

  • Hospitals & Academic Laboratories
  • Clinics & Commercial Laboratories
  • Others

By Regions

  • United States
  • Europe (Expect Russia)
  • India
  • China
  • Japan
  • Brazil
  • South Korea
  • Mexico
  • Russia
  • Rest of World

Table of Contents

1. Executive Summary

2. Global Molecular Diagnostic Market

3. Market Share - Global Molecular Diagnostics

  • 3.1 By Application
  • 3.2 By Technology
  • 3.3 By Countries
  • 3.4 By Companies

4. Application - Molecular Diagnostics Market

  • 4.1 Infectious Diseases
    • 4.1.1 Hospital Acquired Infections (HAI)
    • 4.1.2 HIV / HCV Testing
    • 4.1.3 STD Testing
    • 4.1.4 HPV Testing
  • 4.2 Blood Screening
  • 4.3 Oncology / Cancer
    • 4.3.1 Breast
    • 4.3.2 Colorectal
    • 4.3.3 Prostate
    • 4.3.4 Others
  • 4.4 Genetic Testing
  • 4.5 HLA (Tissue Typing)
  • 4.6 Microbiology
  • 4.7 Cardiovascular Diseases
  • 4.8 Neurological Diseases
  • 4.9 Pharmacogenomics
  • 4.10 Others

5. Technology - Molecular Diagnostics Market

  • 5.1 PCR
  • 5.2 Transcription-Mediated Amplification (TMA)
  • 5.3 Hybridiazation (In-situ Hybridiazation & FISH)
  • 5.4 DNA Sequencing & NGS
  • 5.5 Microarray
  • 5.6 Others

6. Region - Molecular Diagnostics Market

  • 6.1 United States
  • 6.2 Europe
  • 6.3 India
  • 6.4 China
  • 6.5 Japan
  • 6.6 Brazil
  • 6.7 South Korea
  • 6.8 Mexico
  • 6.9 Russia
  • 6.10 Rest of World (ROW)

7. End Users - Molecular Diagnostics Market

  • 7.1 Hospitals & Academic Laboratories
  • 7.2 Clinics and Commercial Laboratories
  • 7.3 Others

8. Roche Diagnostics - Company Analysis

  • 8.1 Merger & Acquisitions
  • 8.2 Sales Analysis

9. Abbott Laboratories - Company Analysis

  • 9.1 Merger & Acquisitions
  • 9.2 Sales Analysis

10. Myriad Genetics - Company Analysis

  • 10.1 Merger & Acquisitions
  • 10.2 Sales Analysis

11. Qiagen - Company Analysis

  • 11.1 Merger & Acquisitions
  • 11.2 Sales Analysis

12. BioMerieux's Inc - Company Analysis

  • 12.1 Merger & Acquisitions
  • 12.2 Sales Analysis

13. Market Drivers

  • 13.1 Various Developments in the Molecular Diagnostics Landscape
  • 13.2 Integral to Traditional Labs
  • 13.3 Improved Assay / Test Efficiencies
  • 13.4 Targeting Antibiotic Resistance
  • 13.5 Next Generation Ultrasensitive Molecular Diagnostics
  • 13.6 Increasing Investment in Genomics & Proteomics Research
  • 13.7 Technological Advances in Molecular Diagnostics
  • 13.8 Increasing Acceptance of the Personalized Medicine
  • 13.9 Growing Molecular Diagnostics for Food Safety

14. Challenges

  • 14.1 Dearth of Trained Professionals
  • 14.2 Regulatory Issues
  • 14.3 Various Factors Slowing Growth of Molecular Diagnostics
  • 14.4 Reimbursement Capabilities
  • 14.5 Quality Checkpoints, Awareness & Acceptance

List of Figures:

  • Figure 2-1: Global- Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 2-2: Global - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 3-1: Global- Molecular Diagnostics Market Share by Application (Percent), 2011 - 2019
  • Figure 3-2: Global- Forecast for Molecular Diagnostics Market Share by Application (Percent)
  • Figure 3-3: Global- Molecular Diagnostics Market Share by Technology (Percent), 2011 - 2019
  • Figure 3-4: Global- Forecast for Molecular Diagnostics Market Share by Technology (Percent)
  • Figure 3-5: Global- Molecular Diagnostics Market Share by Countries (Percent), 2011 - 2019
  • Figure 3-6: Global- Forecast for Molecular Diagnostics Market Share by Countries (Percent)
  • Figure 4-1: Global- Molecular Diagnostics Market by Infectious Diseases (Million US$)
  • Figure 4-2: Global- Forecast for Molecular Diagnostics Market by Infectious Diseases (Million US$), 2020 - 2025
  • Figure 4-3: Global- Molecular Diagnostics Market by Hospital Acquired Infection (Million US$)
  • Figure 4-4: Global- Forecast for Molecular Diagnostics Market by Hospital Acquired Infection
  • Figure 4-5: Global- Molecular Diagnostics Market by HIV/HCV Testing (Million US$), 2011 - 2019
  • Figure 4-6: Global- Forecast for Molecular Diagnostics Market by HIV/HCV Testing (Million US$)
  • Figure 4-7: Global- Molecular Diagnostics Market by STD Testing (Million US$), 2011- 2019
  • Figure 4-8: Global- Forecast for Molecular Diagnostics Market by STD Testing (Million US$)
  • Figure 4-9: Global- Molecular Diagnostics Market by HPV Testing (Million US$), 2011 - 2019
  • Figure 4-10: Global- Forecast for Molecular Diagnostics Market by HPV Testing (Million US$)
  • Figure 4-11: Global- Molecular Diagnostics Market by Blood Screening (Million US$), 2010 - 2019
  • Figure 4-12: Global- Forecast for Molecular Diagnostics Market by Blood Screening (Million US$), 2020 - 2025
  • Figure 4-13: Global- Molecular Diagnostics Market by Oncology (Million US$), 2010 - 2019
  • Figure 4-14: Global- Forecast for Molecular Diagnostics Market by Oncology (Million US$)
  • Figure 4-15: Global- Molecular Diagnostics Market by Breast (Million US$), 2010 - 2019
  • Figure 4-16: Global- Forecast for Molecular Diagnostics Market by Breast (Million US$), 2020 - 2025
  • Figure 4-17: Global- Molecular Diagnostics Market by Colorectal (Million US$), 2010 - 2019
  • Figure 4-18: Global- Forecast for Molecular Diagnostics Market by Colorectal (Million US$)
  • Figure 4-19: Global- Molecular Diagnostics Market by Prostate (Million US$), 2010 - 2019
  • Figure 4-20: Global- Forecast for Molecular Diagnostics Market by Prostate (Million US$), 2020 - 2025
  • Figure 4-21: Global- Molecular Diagnostics Market by Others (Million US$), 2010 - 2019
  • Figure 4-22: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
  • Figure 4-23: Global- Molecular Diagnostics Market by Genetic Testing (Million US$), 2010 - 2018
  • Figure 4-24: Global- Forecast for Molecular Diagnostics Market by Genetic Testing (Million US$)
  • Figure 4-25: Global- Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2011 - 2019
  • Figure 4-26: Global- Forecast for Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2020 - 2025
  • Figure 4-27: Global- Molecular Diagnostics Market by Microbiology (Million US$), 2011 - 2019
  • Figure 4-28: Global- Forecast for Molecular Diagnostics Market by Microbiology (Million US$)
  • Figure 4-29: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2011 - 2019
  • Figure 4-30: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2020 - 2025
  • Figure 4-31: Global- Molecular Diagnostics Market by Neurological Diseases (Million US$), 2011 - 2019
  • Figure 4-32: Global- Forecast for Molecular Diagnostics Market by Neurological Diseases (Million US$), 2020 - 2025
  • Figure 4-33: Global- Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2011 - 2019
  • Figure 4-34: Global- Forecast for Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2020 - 2025
  • Figure 4-35: Global- Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
  • Figure 4-36: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
  • Figure 5-1: Global- Molecular Diagnostics Market by PCR (Million US$), 2011 - 2019
  • Figure 5-2: Global- Forecast for Molecular Diagnostics Market by PCR (Million US$), 2020 - 2025
  • Figure 5-3: Global- Molecular Diagnostics Market by TMA (Million US$), 2011 - 2019
  • Figure 5-4: Global- Forecast for Molecular Diagnostics Market by TMA (Million US$), 2020 - 2025
  • Figure 5-5: Global- Molecular Diagnostics Market by Hybridiazation (Million US$), 2011 - 2019
  • Figure 5-6: Global- Forecast for Molecular Diagnostics Market by Hybridiazation (Million US$)
  • Figure 5-7: Global- Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$)
  • Figure 5-8: Global- Forecast for Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$), 2020 - 2025
  • Figure 5-9: Global- Molecular Diagnostics Market by Microarray (Million US$), 2011 - 2019
  • Figure 5-10: Global- Forecast for Molecular Diagnostics Market by Microarray (Million US$), 2020 - 2025
  • Figure 5-11: Global- Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
  • Figure 5-12: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
  • Figure 6-1: United States - Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2019 - 2028
  • Figure 6-3: Europe - Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-4: Europe - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-5: India -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-6: India - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-7: China - Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-8: China - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-9: Japan -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-10: Japan - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-11: Brazil -Molecular Diagnostics Market (Million US$), 2011 - 2020
  • Figure 6-12: Brazil - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-13: South Korea -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-14: South Korea - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-15: Mexico -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-16: Mexico - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-17: Russia -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-18: Russia - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 6-19: ROW -Molecular Diagnostics Market (Million US$), 2011 - 2019
  • Figure 6-20: ROW - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
  • Figure 7-1: Global - Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2011 - 2019
  • Figure 7-2: Global - Forecast for Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2020 - 2025
  • Figure 7-3: Global - Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2011 - 2019
  • Figure 7-4: Global - Forecast for Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2019 - 2025
  • Figure 7-5: Global - Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
  • Figure 7-6: Global - Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
  • Figure 8-1: Roche - Molecular Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 8-2: Roche - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
  • Figure 9-1: Abbott Laboratories- Molecular Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 9-2: Abbott Laboratories - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
  • Figure 10-1: Myriad Genetics -Molecular Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 10-2: Myriad Genetics - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
  • Figure 11-1: Qiagen -Molecular Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 11-2: Qiagen - Forecast for Molecular Diagnostics Sales (Million US$), 2019 - 2025